Interventional Oncology Devices – Market Insights – Latin America (Supplemental)

Despite the short-term challenges posed by the COVID-19 pandemic, the Latin America interventional oncology device market will see moderate growth through 2031 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will remain a challenge.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for interventional oncology devices in the Latin America region from 2019 through 2031.

Table of contents